ACHIEVE LIFE SCIENCES, INC.

Analyst Reco. Achieve Life Sciences, Inc.

Equities

ACHV

US0044685008

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
4.53 ^USD	-3.72%		-3.41%	+9.95%

May. 09	Transcript : Achieve Life Sciences, Inc., Q1 2024 Earnings Call, May 09, 2024
May. 09	Achieve Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JonesTrading Starts Achieve Life Sciences With Buy Rating, $20 Price Target	Apr. 17	MT
Oppenheimer Adjusts Achieve Life Sciences Price Target to $18 From $21, Maintains Outperform Rating	Dec. 12	MT
Lake Street Adjusts Price Target on Achieve Life Sciences to $19 From $22, Maintains Buy Rating	23-05-31	MT
Oppenheimer Adjusts Achieve Life Sciences Price Target to $17 From $20, Maintains Outperform Rating	23-01-10	MT
Maxim Lowers Price Target on Achieve Life Sciences to $8 From $21, Maintains Buy Rating	22-11-16	MT
Oppenheimer Adjusts Achieve Life Sciences PT to $20 From $27 Given Difficult Current Market Conditions, Maintains Outperform Rating	22-11-15	MT
Oppenheimer Adjusts Price Target on Achieve Life Sciences to $27 From $23, Keeps Outperform Rating	22-04-28	MT
Achieve Life Sciences Says Its Smoking Addiction Treatment Candidate Showed Better Quit Rates Than Placebo in Phase 3 Trial	22-04-27	MT
ACHIEVE LIFE SCIENCES : Alliance Global Partners Starts Achieve Life Sciences at Buy with $25 Price Target	21-10-04	MT
ACHIEVE LIFE SCIENCES : Oppenheimer Initiates Coverage on Achieve Life Sciences With Outperform Rating, $23 Price Target	21-06-23	MT
Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2B Orca-1 Dose-Selection Trial	19-06-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW